Ipilimumab/nivolumab/pembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69043-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[31] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 416 - 416
[32] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 457 - 457
[33] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1919 (1) : 495 - 495
[34] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1900 (1) : 274 - 274
[35] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 366 - 366
[36] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2041 (1) : 330 - 330
[37] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 356 - 356
[38] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 546 - 546
[39] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 331 - 331
[40] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2046 (1) : 340 - 340

← 1 2 3 4 5 →